CD4 and cancer: determined the transcriptomic signature of CD4 + T cell DC licensing in human cancers through scRNA-seq and flow cytometry, cognate interactions of CD4 + T cells and CD8 + T cells with cDC1s can promote CTLs responses and Th1 differentiation, thereby translating into T cell-mediated tumor suppression in multiple human solid tumor types.